Burmester, G., Strand, V., Rubbert-Roth, A., Amital, H., Raskina, T., Gomez-Centeno, A., . . . Genovese, M. (2019). Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH openlabel extension.
Citación estilo ChicagoBurmester, GR, et al. Safety and Efficacy of Switching From Adalimumab to Sarilumab in Patients With Rheumatoid Arthritis in the Ongoing MONARCH Openlabel Extension. 2019.
Cita MLABurmester, GR, et al. Safety and Efficacy of Switching From Adalimumab to Sarilumab in Patients With Rheumatoid Arthritis in the Ongoing MONARCH Openlabel Extension. 2019.
Precaución: Estas citas no son 100% exactas.